RBC Capital Maintains Outperform on Nevro, Lowers Price Target to $33
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Shagun Singh has maintained an 'Outperform' rating on Nevro (NYSE:NVRO), but lowered the price target from $39 to $33.

August 04, 2023 | 11:39 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Nevro's price target has been lowered from $39 to $33 by RBC Capital, though the 'Outperform' rating is maintained.
The lowering of the price target by RBC Capital could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential in the company, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100